| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.6676 | 
      | Human Intestinal Absorption | HIA+ | 0.9925 | 
      | Caco-2 Permeability | Caco2+ | 0.5243 | 
      | P-glycoprotein Substrate | Substrate | 0.6639 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.9211 | 
                                                     | Inhibitor | 0.8784 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7371 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7539 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8357 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8773 | 
      | CYP450 3A4 Substrate | Substrate | 0.6245 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.8169 | 
      | CYP450 2C9 Inhibitor | Inhibitor | 0.5477 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.6410 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.8984 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.6951 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8888 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9485 | 
                                                                    | Non-inhibitor | 0.9025 | 
      | AMES Toxicity | AMES toxic | 0.8624 | 
      | Carcinogens | Non-carcinogens | 0.9346 | 
      | Fish Toxicity | High FHMT | 0.9915 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9962 | 
      | Honey Bee Toxicity | High HBT | 0.9020 | 
      | Biodegradation | Not ready biodegradable | 0.7874 | 
      | Acute Oral Toxicity | III | 0.5497 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5570 |